Big expansion in the US: drug supplier Lonza builds factory for diabetes treatments

class=”sc-29f61514-0 jbwksb”>

Lonza announced Monday that the decision was based on study data showing the effectiveness of a Vertex product to be manufactured here.

Data showed that endogenous insulin (C-peptide) was produced in six patients treated with the product candidate “VX-880”. They also showed improved glycemic control while reducing or eliminating insulin use.

300 new jobs are created

Also, as Lonza explains, patients with a treatment duration greater than 90 days did not experience more severe hypoglycemic events during the evaluation period.

The new manufacturing facility will now be built in Portsmouth, New Hampshire, USA. It will cover an area of ​​approximately 12,000 square meters and will offer up to 300 new jobs at maximum capacity. Construction is scheduled to begin at the end of this year. (SDA)

More about Lonza in Switzerland

Zeneggen needs to be upgraded

Valais mountain village fears drinking water due to Lonza eruption

An immigrant in Valais tells the story

“I miss the beer gardens the most”

Lonza site administrator admits

“Every explosion comes with challenges”

Free flat share, super cheap GA travel card

Lonza advertises on Visp for apprentices with these bonuses

Source :Blick

Tim

I’m Tim David and I work as an author for 24 Instant News, covering the Market section. With a Bachelor’s Degree in Journalism, my mission is to provide accurate, timely and insightful news coverage that helps our readers stay informed about the latest trends in the market. My writing style is focused on making complex economic topics easy to understand for everyone.